ATAT vs BABA

ATAT exhibits exceptional deterministic health with a perfect Piotroski F-Score of 9/9, signaling strong financial quality and operational efficiency. The company's robust profitability metrics—ROE of 49.68%, gross margin of 44.26%, and 33.8% YoY revenue growth—demonstrate superior execution in a cyclical sector. Despite a lack of Altman Z-Score, the low debt/equity ratio (0.43) and strong liquidity (current ratio 1.97) support financial stability. The stock trades below its intrinsic value of $49.85 and Graham Number of $11.99, suggesting significant upside potential, especially given its strong analyst consensus and 214.2% Q/Q EPS growth. However, inconsistent earnings surprises and a bearish technical trend introduce near-term volatility risk.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.